# SPEVIGO
> **BLA761244** · Biologics License Application · Sponsor: BOEHRINGER INGELHEIM PHARMACEUTICALS INC · Approved 2022-09-01
## Drug
- **FDA Application Number:** BLA761244
- **Application type:** Biologics License Application
- **Brand name:** SPEVIGO
- **Generic name:** SPESOLIMAB-SBZO
- **Active ingredients:** SPESOLIMAB-SBZO
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** BOEHRINGER INGELHEIM PHARMACEUTICALS INC
- **Manufacturer:** Boehringer Ingelheim Pharmaceuticals, Inc.
- **First approval:** 2022-09-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761244)
---
*AI Analytics · CC0 1.0*